Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia Metzgeroth

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Blood Neoplasia|June 2, 2025
Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell levelJohann-Christoph Jann, Nanni Schmitt, Alexander Streuer, et al.
Blood|February 15, 2007
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemiaJelena V Jovanovic, Joannah Score, Katherine Waghorn, et al.
British Journal of Haematology|January 24, 2021
High erythroferrone expression in CD71<sup>+</sup> erythroid progenitors predicts superior survival in myelodysplastic syndromesVladimir Riabov, Maximilian Mossner, Alexandra Stöhr, et al.
The World Allergy Organization Journal|January 4, 2013
ICON: Eosinophil DisordersPeter Valent, Amy D Klion, Lanny J Rosenwasser, et al.
American Journal of Hematology|April 13, 2020
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genesJuliana Schwaab, Nicole Naumann, Johannes Luebke, et al.
Cell Stem Cell|April 8, 2014
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unitHind Medyouf, Maximilian Mossner, Johann-Christoph Jann, et al.
Leukemia|June 26, 2021
Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromesNanni Schmitt, Johann-Christoph Jann, Eva Altrock, et al.
Experimental Hematology|December 24, 2021
Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromesEva Altrock, Carla Sens-Albert, Johann-Christoph Jann, et al.
Allergy|October 7, 2022
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromesPeter Valent, Amy D Klion, Florence Roufosse, et al.
Annals of Hematology|April 27, 2021
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)Anna Hecht, Julia A Meyer, Johann-Christoph Jann, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Blood Neoplasia|June 2, 2025
Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell levelJohann-Christoph Jann, Nanni Schmitt, Alexander Streuer, et al.
Blood|February 15, 2007
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemiaJelena V Jovanovic, Joannah Score, Katherine Waghorn, et al.
British Journal of Haematology|January 24, 2021
High erythroferrone expression in CD71<sup>+</sup> erythroid progenitors predicts superior survival in myelodysplastic syndromesVladimir Riabov, Maximilian Mossner, Alexandra Stöhr, et al.
The World Allergy Organization Journal|January 4, 2013
ICON: Eosinophil DisordersPeter Valent, Amy D Klion, Lanny J Rosenwasser, et al.
American Journal of Hematology|April 13, 2020
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genesJuliana Schwaab, Nicole Naumann, Johannes Luebke, et al.
Cell Stem Cell|April 8, 2014
Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unitHind Medyouf, Maximilian Mossner, Johann-Christoph Jann, et al.
Leukemia|June 26, 2021
Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromesNanni Schmitt, Johann-Christoph Jann, Eva Altrock, et al.
Experimental Hematology|December 24, 2021
Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromesEva Altrock, Carla Sens-Albert, Johann-Christoph Jann, et al.
Allergy|October 7, 2022
Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromesPeter Valent, Amy D Klion, Florence Roufosse, et al.
Annals of Hematology|April 27, 2021
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)Anna Hecht, Julia A Meyer, Johann-Christoph Jann, et al.
Pageof 9